FDA infant formula proposed QC batch-testing possibly "burdensome," Sandoz asserts.
This article was originally published in The Tan Sheet
Executive Summary
FDA INFANT FORMULA PROPOSED BATCH-TESTING "BURDENSOME," SANDOZ ARGUES, if it requires full analytical testing for every nutrient in each batch of formula. In Oct. 4 comments, Sandoz Nutrition tells the agency that it is unsure whether the proposed quality control procedures for infant formulas mean that: "a) the manufacturer must conduct full analytical testing on every nutrient in every batch; or b) the manufacturer would test each batch for a premix tracer plus full analytical testing on any nutrients added independently from premixes."